Pfizer Lyrica Will Undergo Phase IV Vision, Nerve Impairment Studies
Executive Summary
Pfizer will study ophthalmologic adverse events in Lyrica patients as a post-marketing commitment for pregabalin
You may also be interested in...
Pfizer Launch Plans For Lyrica Fibromyalgia Approval Include Patient Groups
Pfizer's first steps in marketing Lyrica's new indication for fibromyalgia - the first FDA approval for the condition - will be partnering with patient advocacy groups to raise awareness and conduct educational programs
Pfizer Launch Plans For Lyrica Fibromyalgia Approval Include Patient Groups
Pfizer's first steps in marketing Lyrica's new indication for fibromyalgia - the first FDA approval for the condition - will be partnering with patient advocacy groups to raise awareness and conduct educational programs
Pfizer Lyrica Launch Awaits Controlled Substance Scheduling
Pfizer's launch of Lyrica will be delayed while pregabalin undergoes controlled substance scheduling at the Drug Enforcement Administration